Augmentation of antidepressants with bright light therapy in patients with comorbid depression and borderline personality disorder

Biomedical Papers

Volumn 154, Issue 4, 2010, Pages 355-362

  Prasko, Jan ^a,b,c,d   Brunovsky, Martin ^c,d   Latalova, Klara ^a,b   Grambal, Ales ^a,b   Raszka, Michal ^c,d   Vyskocilova, Jana ^c   Zavesicka, Lucie ^c,d  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Borderline personality disorderComorbidity; Bright light therapy; Depressive episode; Non seasonal depressive disorder; Open stud y; Resistance to therapy

Indexed keywords

PRENANTHELLA EXIGUA;

EID: 78650829261     PISSN: 12138118     EISSN: 12138118     Source Type: Journal    
DOI: 10.5507/bp.2010.053     Document Type: Article

References (26)

1. Phillips KA and Gunderson JG. Personality disorders, in The American Psychiatric Press Textbook of Psychiatry, 3rd ed. Edited by Hales RE, Yudofsky SC, Talbott JA. American Psychiatric Press, Washington DC 1999; 795-823.
2. Corbitt EM and Widiger TA. Sex differences among the personality disorder. An exploration of the data. Clin Psychol Sci Pract 1995; 2:225-238.
3. Linehan MM and Kehrer CA. Borderline personality disorder. In: Barlow, D.H. (ed.): Clinical handbook of psychological disorders. A step-by-step treatment manual. The Guilford Press, New York 1993; 396-441.
4. Markowitz P. Pharmacotherapy of impulsivity, aggression, and re-lated disorders, in Impulsivity and Aggression. Edited by Hollander E, Stein DJ. New York, John Wiley & Sons 1995; 263-287.
5. Siever LJ. Evaluation framework for biological correlates of per-sonality disorder. Psychiatr Times 1990; 7:17-19.
6. Silk KR. Borderline personality disorder. Overview of biological factors. Psychiatr Clin N Am 2000; 23:61-75.
7. Gunderson JG. Borderline Personality Disorder: A Clinical Guide. American Psychiatric Press, Washington DC 2001.
8. American Psychiatric Association: Practice Guidelines for the Treatment of Patients with Borderline Personality Disorder. Washington, DC, APA 2001.
9. Markowitz P. Pharmacotherapy. In: Livesley WJ (ed): Handbook of Personality Disorders. Guilford Press, New York 2001; 475-493.
10. Praško J, Herman E, Horáček J et al. Poruchy osobnosti. Praha: Portál 2003; 360p.
11. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, Schwartz J, Miyawaki E. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995; 15:23-29.
12. Markowitz PJ, Calabrese JR, Charles SC, Meltzer HY. Fluoxetine in the treat- ment of borderline and schizotypal personality disorders. Am J Psychiatry 1991; 148:1064-1067.
13. Markowitz PJ and Wagner C. Venlafaxine in the treatment of borderline personality disorder. Psychopharmacol Bull 1995; 31:773-777.
14. Cornelius JR, Soloff PH, Perel JM et al. Fluoxetine trial in borderline personality disorder. Psychopharmacol Bull 1990; 26:151-154.
15. Kavoussi RJ, Liu J, Coccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994; 55:137-141.
16. Norden MJ. Fluoxetine in borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13:885-893.
17. Praško J, Horáček J, Klaschka J et al. Bright light therapy and/orimipramine for inpatients with recurrent non seasonal depression. Neuro Endocrinol Lett 2002; 23:109-113.
18. Illnerová H, Borbély AA, Wirz-Justice A, Praško J. Circadian rhythmicity: from basic science to clinical approach. Suppl Clin Neurophysiol 2000; 53:339-347.
19. Praško J, Houbová P, Novák T, Záleský R, Espa-Červená K, Pašková B, Vyskočilová J. Influence of personality disorder on the treatment of panic disorder-comparison study. Neuro Endocrinol Lett 2005; 26:667-674.
20. Lecrubier Y, Sheehan DV, Weiller E et al. The MINI-international neuropsychiatric interview (M.I.N.I.): a short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997; 12:224-231.
21. Guy W (ed.). ECDEU Assessment manual for psychopharmacology. Rockville, U.S. DHEW 1976.
22. Hamilton M. Development of a Rating Scale for Primary Depressive Illness. Brit J Soc Clin Psychol 1967; 6:278-296.
23. Montgomery SA, Asberg M. A New Depression Scale Designed to be Sensitive to Change. Brit J Psychiatry 1979; 134:382-389.
24. Beck AT and Beamesderfer A. Assessment of Depression: The Depression Inventory. In: Psychological Measurements in Psychopharmacology 1974; 7:151-169.
25. Beck AT and Emery G. Anxiety disorders and phobias: A cognitive perspective. New York, Basic Books 1985.
26. Eastman C. What the placebo literature can tell us about photo- therapy for SAD. Psychopharmacol Bull 1990; 26:495-504.